Search results
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 3 days agoBeyond that, Dr. Schaffner recommends doing your best to avoid crowded indoor activities, especially...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 4 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated COVID-19 vaccine in pre-filled syringes ...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 17 hours agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 7 days agoFDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held off on...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 4 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
The COVID KP.3 Variant Makes Up 25% of U.S. Cases: Can Rapid Tests Detect It?
Verywell Health via Yahoo News· 2 hours agoThe KP.3 variant, one of the three "FLiRT" variants, was the most dominant in the U.S. as of early...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 7 days agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
Coronavirus company news summary – US FDA authorises LetsGetChecked’s home collection Covid-19 test...
Medical Device Network via Yahoo Finance· 3 days agoFDA Authorization of Let’sGetChecked’s Home Collection COVID-19 Test LetsGetChecked has announced that the US Food and Drug Administration ...
Health Essentials: Where to Buy an At-Home COVID-19 Test Online for Cheap
Billboard via Yahoo News· 3 days agoIf you have health insurance, you may be able to receive an FDA authorized at-home COVID test for...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 22 hours agoOn Thursday, Argus increased its price target on Moderna (NASDAQ:MRNA) shares listed on NASDAQ:MRNA...